Latest News and Press Releases

WINNIPEG, MANITOBA--(Marketwired - Feb. 12, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company developing and commercializing products that prevent and remove microbial...

WINNIPEG, MANITOBA--(Marketwired - Jan. 12, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...

WINNIPEG, MANITOBA--(Marketwired - Dec. 23, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on December 19, 2014, it issued 251,392 common shares of the...

WINNIPEG, MANITOBA--(Marketwired - Dec. 17, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech"), a biotechnology company engaged in the development of products...

WINNIPEG, MANITOBA--(Marketwired - Dec. 9, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech"), a biotechnology company engaged in the development of products...

WINNIPEG, MANITOBA--(Marketwired - Nov. 19, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...

WINNIPEG, MANITOBA--(Marketwired - Nov. 10, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") today announced an amendment to the terms of the previous announced non-brokered...

WINNIPEG, MANITOBA--(Marketwired - Oct. 8, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company developing and commercializing products that prevent and remove microbial...

WINNIPEG, MANITOBA--(Marketwired - Oct. 6, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") today announced the intention of the Corporation to undertake a non-brokered...

WINNIPEG, MANITOBA--(Marketwired - Sept. 24, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on September 23, 2014, it issued 254,178 common shares of the...